[PRESS RELEASE – Lausanne, Switzerland, January 15th, 2026] SwissBorg, Europe’s leading app for investing and earning crypto, today announced the integration of[PRESS RELEASE – Lausanne, Switzerland, January 15th, 2026] SwissBorg, Europe’s leading app for investing and earning crypto, today announced the integration of

SwissBorg Meta-Exchange Integrates Base

[PRESS RELEASE – Lausanne, Switzerland, January 15th, 2026]

SwissBorg, Europe’s leading app for investing and earning crypto, today announced the integration of Base into its Meta-Exchange (MEX), expanding access to the fast-growing Layer 2 ecosystem. Through this connection, SwissBorg users gain deeper liquidity routes, better access to emerging Base-native tokens, and lower-slippage execution.

As part of the integration, the Meta-Exchange now supports liquidity from key Base DEXs, including Uniswap, PancakeSwap, and Aerodrome, the network’s native liquidity layer optimised for capital efficiency and early-stage token markets. Additional integrations will follow as the ecosystem matures.

SwissBorg’s Meta-Exchange aggregates liquidity from centralized exchanges, decentralized exchanges, and fiat rails, consolidating them into a unified, intuitive trading experience. The integration of Base maintains the app’s one-tap simplicity and removes the complexities of cross-chain interaction.

Base, built on the OP Stack in collaboration with Coinbase, offers a fast, low-cost environment with EVM compatibility and an expanding developer ecosystem. With high throughput and inexpensive transactions, Base has positioned itself as a highly active hub for DeFi, consumer-facing applications, and emerging token launches.

By connecting to Base, SwissBorg continues to extend its multi-chain liquidity infrastructure, adding to recent integrations such as Solana, Avalanche, Berachain, Hyperliquid, and BNB Chain. Users can swap Base-native assets against any SwissBorg-supported token in a single tap, without needing external wallets, bridges, or network switching.

The addition of Base is another step forward in SwissBorg’s mission to build the most powerful cross-chain liquidity layer broader vision, as the Meta-Exchange delivers more liquidity, broader token access, and less friction through a single, seamless interface.

About SwissBorg

SwissBorg is the leading community-driven crypto wealth management platform, engineered in Switzerland and licensed in the EU. Committed to trust and transparency, SwissBorg is on a mission to democratise the future of finance to make financial freedom possible for everyone. At its core is the groundbreaking Meta-Exchange, which seamlessly connects to multiple centralised and decentralised exchanges to secure the best liquidity and prices for users. Beyond trading, SwissBorg offers curated yield strategies through DeFi, and empowers users to access early Web3 opportunities through its Alpha Pre-Sales. Swissborg’s token, BORG, sits at the heart of their ecosystem providing a multitude of benefits to its holders.

Website | X | LinkedIn | Discord

Base Network

Base is an Ethereum Layer 2 (L2) network that provides a secure, low-cost, and developer-friendly environment for building decentralized applications. Its mission is to help make onchain the next online and support the onboarding of more than one billion users into the cryptoeconomy. Designed to serve as both the home for Coinbase’s onchain products and an open ecosystem for builders everywhere, Base aims to create an accessible, scalable foundation for the next generation of onchain applications and communities.

Website | X | Discord

The post SwissBorg Meta-Exchange Integrates Base appeared first on CryptoPotato.

Market Opportunity
xExchange Logo
xExchange Price(MEX)
$0.000000667
$0.000000667$0.000000667
+1.21%
USD
xExchange (MEX) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26